SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009341
Filing Date
2022-05-11
Accepted
2022-05-11 16:14:44
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sctl-20220331.htm   iXBRL 10-Q 1597442
2 EX-31.1 sctl-ex31_1.htm EX-31.1 15956
3 EX-31.2 sctl-ex31_2.htm EX-31.2 15934
4 EX-32.1 sctl-ex32_1.htm EX-32.1 10135
  Complete submission text file 0000950170-22-009341.txt   7896992

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sctl-20220331_cal.xml EX-101.CAL 47191
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20220331_pre.xml EX-101.PRE 402764
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20220331_lab.xml EX-101.LAB 552424
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20220331.xsd EX-101.SCH 57975
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sctl-20220331_def.xml EX-101.DEF 209091
71 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20220331_htm.xml XML 1479580
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 22913885
SIC: 2834 Pharmaceutical Preparations